pharma · Chronic Lymphocytic Leukemia (CLL) · Chronic Lymphocytic Leukemia · APVO
Aptevo Therapeutics
Aptevo Therapeutics clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Seattle, USA HQ
2016 Founded
54 Employees
Public company Type
APVO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Seattle, USA
- Founded
- 2016
- Employees
- 54
- Programs
- 9
- Drugs
- 4
- Patents
- 13
Aptevo Therapeutics projects
0 ClinicalTrials.gov programs sponsored by Aptevo Therapeutics.
Aptevo Therapeutics has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Aptevo Therapeutics have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.